Clinical Trial to Evaluate the Efficacy and Safety of JP-1366 in Patients With Gastric Ulcer

Condition:   Gastric Ulcer Interventions:   Drug: JP-1366 20mg;   Drug: Lansoprazole 30mg Sponsor:   Onconic Therapeutics Inc. Not yet recruiting

Source: ClinicalTrials.gov - July 7, 2022 Category: Research Source Type: clinical trials